FDA Adverse Event Injury Summary report: N

IFS

MDR report key: 7239009 · Received February 2, 2018

Report

Report Number
3006695864-2018-00187
Event Type
Injury
Date Received
February 2, 2018
Date of Event
January 5, 2018
Report Date
March 9, 2018
Manufacturer
ABBOTT MEDICAL OPTICS
Product Code
HNO
UDI-DI
05050474573468
PMA / PMN Number
K060372
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DEVICE EVALUATION: A REVIEW OF THE RECORDS RELATED TO THE DEVICE THAT INCLUDED LABELING, MANUALS, TRENDING, AND RISK DOCUMENTATION WAS PERFORMED. THE TREND REVIEW SHOWS THAT THERE IS NOT SIGNIFICANT CHANGE OVER HISTORICAL COMPLAINT LIMITS AND NO RECOGNIZABLE ADVERSE TREND. THE RISKS AND MITIGATIONS ASSOCIATED WITH THE COMPLAINT ISSUE ARE IDENTIFIED IN EXISTING RISK DOCUMENTS AND NO NEW RISKS WERE IDENTIFIED AS PART OF THIS INVESTIGATION. THERE WAS NO PRODUCT DEFICIENCY IDENTIFIED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 0

CORRECTED DATA: THIS REPORT IS BEING SUBMITTED AS FOLLOW-UP NUMBER ONE (1) FOR MANUFACTURER REPORT NUMBER 3006695864-2018-00187. IN REVIEW, WHAT SHOULD HAVE BEEN FOLLOW-UP #1 WAS INADVERTENTLY SUBMITTED WITH THE NUMBER TWO (2) POPULATED IN SECTION G6 TYPE OF REPORT FOLLOW-UP #. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). FIELD SERVICE SPECIALIST VISITED THE ACCOUNT AND CHECKED SYSTEM. SYSTEM WAS OK AND PREVENTIVE MAINTENANCE WAS PERFORMED. COMPLETED FEMTO STANDARD SERVICE CALL CHECK LIST AND SYSTEM MEETS SPECIFICATIONS. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A LASER VISION CORRECTION PATIENT HAD SURGERY ON (B)(6) 2018 AND PRESENTED ON (B)(6) 2018 WITH TRACE 1+ CELL DIFFUSE LAMELLAR KERATITIS (DLK) IN THE LEFT EYE AND STAGE 1+ DIFFUSE LAMELLAR KERATITIS (DLK) IN THE RIGHT EYE. THE TOPICAL STEROID DOSAGE WAS INCREASED UNTIL IT RESOLVED. IT WAS STATED THAT THE PATIENT HAD NO LOSS OF BEST CORRECTED VISUAL ACUITY (BCVA) AND NO SURGICAL INTERVENTION WAS PERFORMED. SURGEON REPORTED THAT ALL EYES NOTED TO HAVE DLK HAD BLEEDING DUE TO SMALL EYES AND BELIEVES THIS MAY HAVE BEEN A FACTOR. HE ALSO STATED THAT THE LIFTS WERE VERY EASY AND HE DROPPED HIS BED ENERGY FROM .85 TO .80. PATIENT POST OP UNCORRECTED VISUAL ACUITY (UCVA) 20/20 BOTH EYES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
79440 IFS FEMTOSECOND LASER HNO ABBOTT MEDICAL OPTICS J20007D 05050474573468

Patients

Seq Age Sex Outcome Treatment
1 27 YR Male Required Intervention